45 participants
The Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMPL-523 in Immune Thrombocytopenia Patients
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2024-07-16
- Start Date:
- 2019-08-12
- Completion:
- 2021-10-30
Conditions
- Immune Thrombocytopenia (ITP)
Interventions
- DRUG
No Results Yet